dsm-firmenich and its partner Novonesis have announced the EU regulatory approval of the feed protease ProAct 360.
The product has been designed for the effective management of protein uptake in all fattening poultry and in chickens reared for laying and breeding.
The company said ProAct 360 benefits the poultry industry in terms of feed efficiency, affordability and sustainability. It breaks down protein faster across a broad range of feed ingredients, delivers greater digestibility of all amino acids and better degrades anti-nutritional factors—leading to improved consistency of response and higher return on investment.
The firm said the product permits the formulation of lower-protein diets with a reduced proportion of soybean meal, which reduces the environmental impact of poultry production while at the same time contributing to improved intestinal health and animal welfare.
Adam Smith, feed optimisation marketing & business development manager at dsm-firmenich Animal Nutrition & Health said: “The issue of EU regulatory approval for ProAct 360 promises significant benefits for poultry farmers in this region and underlines the dsm-firmenich and Novonesis alliance’s commitment to providing value-adding, sustainable solutions for the global feed and animal protein industry.”